NEURODISCOVERY AI
Live / Registered — Registered (as of 14 Jul 2026)
What this means for you
Registered since 14 Jul 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 14 Jul 2032: the §8 declaration of use).
Record
- Serial number
- 98910046
- Registration number
- 8347355
- Mark type
- Design + words
- Filed
- 18 Dec 2024
- Published for opposition
- 08 Jul 2025
- Registered
- 14 Jul 2026
- Next maintenance filing
- §8 declaration of use, due by 14 Jul 2032 (grace period to 14 Jan 2033)
- Attorney of record
- Paul Martello
Goods and services
- Class 035 — Advertising and business services: Business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; Recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs
- Class 042 — Scientific and technological services: Biotechnology research; Drug discovery services; Medical research; Platform as a service (PAAS) featuring computer software platforms for data licensing, analyzing patient medical records and analyzing healthcare data to provide insights on medical treatment effectiveness and safety, enrolling patients in clinical trials, identifying prospective patients for clinical trials, optimizing workflows and databases for medical service providers, and detecting and monitoring biomarkers related to neurological diseases and disorders; Scientific research; Scientific research consulting in the field of clinical trials and neurology; Software as a service (SAAS) services featuring software for data licensing, analyzing patient medical records and analyzing healthcare data to provide insights on medical treatment effectiveness and safety, enrolling patients in clinical trials, identifying prospective patients for clinical trials, optimizing workflows and databases for medical service providers, and detecting and monitoring biomarkers related to neurological diseases and disorders
Owner
- NEURODISCOVERY AI, INC., Alpharetta, GA, US
- NEURODISCOVERY AI, INC., Alpharetta, GA, US
- NEURODISCOVERY AI, INC., Alpharetta, GA, US
Prosecution history
- 14 Jul 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 14 Jul 2026 — REGISTERED-PRINCIPAL REGISTER
- 24 Jun 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 24 Jun 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 09 Jun 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 23 Feb 2026 — USE AMENDMENT FILED
- 23 Feb 2026 — TEAS STATEMENT OF USE RECEIVED
- 02 Sept 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 08 Jul 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Jul 2025 — PUBLISHED FOR OPPOSITION
- 02 Jul 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 05 Jun 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 04 Jun 2025 — ASSIGNED TO EXAMINER
- 26 May 2025 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 26 May 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED